Preclinical evaluation of a fully human, quadrivalent-hantavirus polyclonal antibody derived from a non-human source

IF 5.1 1区生物学 Q1 MICROBIOLOGY

mBio Pub Date : 2024-09-11 DOI:10.1128/mbio.01600-24

Rebecca L. BrocatoHua WuSteven A. KwilasLucia M. PrincipeMatthew JosleynJoshua ShamblinPadmanabh ChivukulaChristoph BauschThomas LukeEddie J. SullivanJay W. Hooper1Virology Division, USA Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Maryland, USA2SAB Biotherapeutics Inc., Sioux Falls, South Dakota, USA3Arcturus Therapeutics Inc., San Diego, California, USAT. C. Wu

引用次数: 0

Abstract

mBio, Ahead of Print.

查看原文本刊更多论文

从非人类来源提取的全人类四价汉坦病毒多克隆抗体的临床前评估

mBio, Ahead of Print.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

mBio MICROBIOLOGY-

CiteScore

10.50

自引率

3.10%

发文量

762

审稿时长

1 months

期刊介绍： mBio® is ASM''s first broad-scope, online-only, open access journal. mBio offers streamlined review and publication of the best research in microbiology and allied fields.

文献相关原料

公司名称	产品信息	采购帮参考价格